Superiority of mature differentiated cultured human corneal endothelial cell injection therapy for corneal endothelial failure
PURPOSE - To investigate the safety and efficacy of cultured human corneal endothelial cell (hCEC) injection therapy with mature differentiated (mature) cell subpopulations (SPs) for corneal endothelial failure (CEF). - DESIGN - Comparative, interventional case series. - METHODS - This study involve...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 2022
|
| In: |
American journal of ophthalmology
Year: 2022, Jahrgang: 237, Pages: 267-277 |
| ISSN: | 1879-1891 |
| DOI: | 10.1016/j.ajo.2021.11.012 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ajo.2021.11.012 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0002939421005948 
|
| Verfasserangaben: | Morio Ueno, Munetoyo Toda, Kohsaku Numa, Hiroshi Tanaka, Kojiro Imai, John Bush, Satoshi Teramukai, Naoki Okumura, Noriko Koizumi, Akihisa Yamamoto, Motomu Tanaka, Chie Sotozono, Junji Hamuro, and Shigeru Kinoshita |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1814741925 | ||
| 003 | DE-627 | ||
| 005 | 20230427130703.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220819s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajo.2021.11.012 |2 doi | |
| 035 | |a (DE-627)1814741925 | ||
| 035 | |a (DE-599)KXP1814741925 | ||
| 035 | |a (OCoLC)1361706428 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ueno, Morio |e VerfasserIn |0 (DE-588)1266033629 |0 (DE-627)1814923543 |4 aut | |
| 245 | 1 | 0 | |a Superiority of mature differentiated cultured human corneal endothelial cell injection therapy for corneal endothelial failure |c Morio Ueno, Munetoyo Toda, Kohsaku Numa, Hiroshi Tanaka, Kojiro Imai, John Bush, Satoshi Teramukai, Naoki Okumura, Noriko Koizumi, Akihisa Yamamoto, Motomu Tanaka, Chie Sotozono, Junji Hamuro, and Shigeru Kinoshita |
| 264 | 1 | |c May 2022 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 14 November 2021 | ||
| 500 | |a Gesehen am 19.08.2022 | ||
| 520 | |a PURPOSE - To investigate the safety and efficacy of cultured human corneal endothelial cell (hCEC) injection therapy with mature differentiated (mature) cell subpopulations (SPs) for corneal endothelial failure (CEF). - DESIGN - Comparative, interventional case series. - METHODS - This study involved 18 eyes with CEF that underwent cultured hCEC injection therapy, categorized into 2 groups: (1) 11 eyes administered a relatively lower proportion (0.1 to 76.3%) of mature cell SPs (group 1 [Gr1]), and (2) 7 eyes administered a relatively higher proportion (>90%) of mature cell SPs (group 2 [Gr2]). From 1 week to 3 years postoperation, corneal endothelial cell (CEC) density (CECD), central corneal thickness (CCT), and best-corrected visual acuity (BCVA) were recorded, and the CEC parameter's “spring constant” was calculated. The proportion of mature SPs was evaluated by fluorescence-activated cell sorting analysis based on cell-surface markers. - RESULTS - At 3 years postoperation, corneal restoration with improved BCVA was attained in 10 of the 11 Gr1 eyes and all Gr2 eyes, the median CECD in Gr2 (3083 cells/mm2; range, 2182-4417 cells/mm2) was higher than that in Gr1 (1349 cells/mm2; range, 746-2104 cells/mm2) (P < .001), and the spring constant verified the superiority of the mature cultured hCECs. From 24 weeks through 3 years postoperation, the median percentage of CECD decrease was 3.2% in Gr2 and 23.6% in Gr1 (P < .005). CCT recovery was prompt and constant in Gr2, while diverse in Gr1. No adverse events were observed. - CONCLUSION - Our findings showed that mature cell SPs for hCEC injection therapy provide rapid recovery of CCT, better CECD, and low CECD attrition over 3 years postsurgery. | ||
| 700 | 1 | |a Toda, Munetoyo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Numa, Kohsaku |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tanaka, Hiroshi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Imai, Kojiro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bush, John |e VerfasserIn |4 aut | |
| 700 | 1 | |a Teramukai, Satoshi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Okumura, Naoko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Koizumi, Noriko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yamamoto, Akihisa |e VerfasserIn |0 (DE-588)1156564840 |0 (DE-627)1019363118 |0 (DE-576)502257032 |4 aut | |
| 700 | 1 | |a Tanaka, Motomu |e VerfasserIn |0 (DE-588)1060648377 |0 (DE-627)800414829 |0 (DE-576)416774636 |4 aut | |
| 700 | 1 | |a Sotozono, Chie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hamuro, Junji |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kinoshita, Shigeru |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of ophthalmology |d New York, NY : Elsevier Science, 1918 |g 237(2022) vom: Mai, Seite 267-277 |h Online-Ressource |w (DE-627)320596281 |w (DE-600)2019600-3 |w (DE-576)121466353 |x 1879-1891 |7 nnas |a Superiority of mature differentiated cultured human corneal endothelial cell injection therapy for corneal endothelial failure |
| 773 | 1 | 8 | |g volume:237 |g year:2022 |g month:05 |g pages:267-277 |g extent:11 |a Superiority of mature differentiated cultured human corneal endothelial cell injection therapy for corneal endothelial failure |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ajo.2021.11.012 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0002939421005948 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220819 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1060648377 |a Tanaka, Motomu |m 1060648377:Tanaka, Motomu |d 120000 |d 120300 |e 120000PT1060648377 |e 120300PT1060648377 |k 0/120000/ |k 1/120000/120300/ |p 11 | ||
| 999 | |a KXP-PPN1814741925 |e 4181036383 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Available online 14 November 2021","Gesehen am 19.08.2022"],"title":[{"title_sort":"Superiority of mature differentiated cultured human corneal endothelial cell injection therapy for corneal endothelial failure","title":"Superiority of mature differentiated cultured human corneal endothelial cell injection therapy for corneal endothelial failure"}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"May 2022"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"person":[{"role":"aut","given":"Morio","family":"Ueno","display":"Ueno, Morio"},{"family":"Toda","display":"Toda, Munetoyo","role":"aut","given":"Munetoyo"},{"display":"Numa, Kohsaku","family":"Numa","role":"aut","given":"Kohsaku"},{"display":"Tanaka, Hiroshi","family":"Tanaka","given":"Hiroshi","role":"aut"},{"role":"aut","given":"Kojiro","display":"Imai, Kojiro","family":"Imai"},{"role":"aut","given":"John","display":"Bush, John","family":"Bush"},{"role":"aut","given":"Satoshi","display":"Teramukai, Satoshi","family":"Teramukai"},{"display":"Okumura, Naoko","family":"Okumura","given":"Naoko","role":"aut"},{"role":"aut","given":"Noriko","family":"Koizumi","display":"Koizumi, Noriko"},{"family":"Yamamoto","display":"Yamamoto, Akihisa","role":"aut","given":"Akihisa"},{"given":"Motomu","role":"aut","family":"Tanaka","display":"Tanaka, Motomu"},{"role":"aut","given":"Chie","family":"Sotozono","display":"Sotozono, Chie"},{"display":"Hamuro, Junji","family":"Hamuro","given":"Junji","role":"aut"},{"display":"Kinoshita, Shigeru","family":"Kinoshita","role":"aut","given":"Shigeru"}],"id":{"eki":["1814741925"],"doi":["10.1016/j.ajo.2021.11.012"]},"relHost":[{"id":{"zdb":["2019600-3"],"issn":["1879-1891"],"eki":["320596281"]},"name":{"displayForm":["Frank W. Newell, ed.-in-chief [u.a.]"]},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["Nachgewiesen 3.Ser. 1.1918 -"],"recId":"320596281","titleAlt":[{"title":"AJO"}],"note":["Gesehen am 21.09.2020","Ungezählte Beil.: Supplement"],"origin":[{"publisher":"Elsevier Science","dateIssuedKey":"1918","publisherPlace":"New York, NY","dateIssuedDisp":"1918-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title_sort":"American journal of ophthalmology","subtitle":"AJO","title":"American journal of ophthalmology"}],"part":{"extent":"11","volume":"237","year":"2022","pages":"267-277","text":"237(2022) vom: Mai, Seite 267-277"},"language":["eng"],"disp":"Superiority of mature differentiated cultured human corneal endothelial cell injection therapy for corneal endothelial failureAmerican journal of ophthalmology"}],"physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Morio Ueno, Munetoyo Toda, Kohsaku Numa, Hiroshi Tanaka, Kojiro Imai, John Bush, Satoshi Teramukai, Naoki Okumura, Noriko Koizumi, Akihisa Yamamoto, Motomu Tanaka, Chie Sotozono, Junji Hamuro, and Shigeru Kinoshita"]},"recId":"1814741925"} | ||
| SRT | |a UENOMORIOTSUPERIORIT2022 | ||